stockrowLivaNova PLC
LIVN Healthcare Medical Devices
LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024.
- Revenue
- +9.88%
- EPS
- +27.4%
- Free cash flow
- −31.0%
- Total debt
- −31.2%
Quarter to September 2026, against a year earlier
Follow LIVN
Alert me
LivaNova PLC (LIVN) Revenue growth
LivaNova PLC's revenue growth over the twelve months to 30 September 2026 was 11.7%, up 1.0 percentage points from fiscal 2025 (10.7%). Over the past ten years it has ranged from −13.8% (fiscal 2020) to 230.9% (fiscal 2016); the current reading is higher than 73% of that period. That is above the Medical Devices industry median of 10.4% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 10.7% | 2.08 |
| FY2024 | 8.66% | (4.23) |
| FY2023 | 12.9% | 14.20 |
| FY2022 | −1.31% | (12.13) |
| FY2021 | 10.8% | 24.65 |
| FY2020 | −13.8% | (11.77) |
| FY2019 | −2.06% | (11.41) |
| FY2018 | 9.35% | 4.44 |
| FY2017 | 4.91% | (226.02) |
| FY2016 | 230.9% | 227.55 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 9.88% | (0.92) |
| Jun 2026 | 10.8% | (3.53) |
| Mar 2026 | 14.3% | 2.18 |
| Dec 2025 | 12.2% | (0.31) |
| 45 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| AXGN AxoGen, Inc. compare | 24.3% |
| IRTC iRhythm Holdings, Inc. compare | 21.6% |
| LIVN LivaNova PLC | 11.7% |
| HAE Haemonetics Corporation compare | 4.11% |
| BRKR Bruker Corporation compare | 2.16% |
| BIO Bio-Rad Laboratories, Inc. compare | 1.38% |
| ITGR Integer Holdings Corporation compare | −0.31% |
| NEOG Neogen Corporation compare | −0.33% |
| TXG 10x Genomics compare | −4.28% |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on LIVN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement